Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
13.06.2025 09:00:24

EQS-Adhoc: The Platform Group AG: Start of entry into the optician and hearing acoustics market through the acquisition of two groups of companies with 30 locations

EQS-Ad-hoc: The Platform Group AG / Key word(s): Mergers & Acquisitions/Takeover
The Platform Group AG: Start of entry into the optician and hearing acoustics market through the acquisition of two groups of companies with 30 locations

13-Jun-2025 / 09:00 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


The Platform Group AG: Start of entry into the optician and hearing acoustics market through the acquisition of two groups of companies with 30 locations

Düsseldorf, 13 
June 2025. The Management Board of The Platform Group AG („TPG“, the „Company“, ISIN: DE000A2QEFA1) has resolved, with the approval of the Supervisory Board, to acquire two groups of companies in the optician and hearing acoustics sector. These transactions constitute the first steps of the Company‘s entry into this market.

As part of the transactions, The Platform Group AG will acquire majority interests in the two optician groups Beste Aussichten GmbH and Karrasch & Nolte GmbH, both headquartered in Münster. The two companies operate a total of around 30 locations in Germany with approximately 200 employees.

The transactions each take the form of share deals. The purchase price is in the double-digit million-euro range and consists of a cash component, which is financed from own funds, and share compensation to the sellers. The parties have agreed not to disclose the exact purchase price. Closing is expected to take place in July 2025.

As part of the first step toward entering the optical and hearing acoustics market, the two companies will be merged with the “MyGlasses” online platform. In a second step, numerous other optician and hearing acoustics companies in Germany and other EU countries are to be acquired until the end of 2026. In a third step, the MyGlasses online platform is to be opened to external opticians from the end of 2025. Given the future importance of the business area and the further planned acquisitions, TPG will introduce a separate segment as part of Group segment reporting from the second half of 2025.

The new “Optics & Hearing” segment is expected to generate sales of over EUR 30 million and adjusted EBITDA of EUR 8 million to EUR 10 million in the 2025 financial year on a pro forma basis. The forecast EBITDA margin (adjusted) is at least 25%.

Contact:

Investor Relations
Bjoern Minnier, CFO and Head of IR
ir@the-platform-group.com
Schloss Elbroich | Am Falder 4 | 40589 Düsseldorf | Germany
corporate.the-platform-group.com



End of Inside Information

13-Jun-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: The Platform Group AG
Schloss Elbroich, Am Falder 4
40589 Düsseldorf
Germany
E-mail: ir@the-platform-group.com
Internet: https://the-platform-group.com/
ISIN: DE000A2QEFA1
WKN: A2QEFA
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Oslo
EQS News ID: 2154660

 
End of Announcement EQS News Service

2154660  13-Jun-2025 CET/CEST

Analysen zu The Platform Group AG Inhaber-Akt

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer

Tim Schäfer live aus New York – dieses Mal mit einem spannenden Blick auf abgestürzte Blue-Chip-Aktien, bei denen sich ein Einstieg lohnen könnte. Gemeinsam mit David Kunz analysiert Tim prominente Verlierer der letzten Monate, die möglicherweise vor einer Erholung stehen.

Themen im Video:
🔹 Merck & Co. (USA) – Probleme mit Impfstoffen und Patentlaufzeiten
🔹 Pfizer – Wachstumsdruck durch auslaufende Patente
🔹 United Health – Ermittlungen und steigende Gesundheitskosten
🔹 Novo Nordisk – Abnehmspritze, Wettbewerb und Marktkorrektur
🔹 Nike – Konsumflaute und neue Konkurrenz
🔹 Estée Lauder – Kursabsturz, China-Schwäche und Hoffnung auf Turnaround
🔹 Campbell Soup – Value-Aktie mit attraktiver Dividende
🔹 Regeneron – Erfolgreiche Gründerstory mit Herausforderungen

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abgestürzte Blue Chip Aktien – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’632.07 19.76 BNRSDU
Short 12’909.40 13.58 BVKSPU
Short 13’370.11 8.93 1CUBSU
SMI-Kurs: 12’146.02 13.06.2025 17:31:20
Long 11’614.68 18.99 BWYSZU
Long 11’366.40 13.58 BBWS3U
Long 10’873.90 8.80 BMQS4U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}